Contrasting Views on Weight Loss Drugs and Health Policies

This chapter explores the conflicting perspectives of two key figures in Donald Trump's administration regarding the use of weight loss drugs like Ozempic and Monjaro. It delves into the broader implications for public health, obesity, and healthcare policies as the administration prepares to take office.